Our Chairman has today welcomed the appointment of Tim Howe QC to our Board of Trustees. Mr. Howe QC is a senior commercial Barrister, specialising in the banking, financial services, energy and insurance industries, will begin his tenure on 16th October.
Mr. Howe was called to the Bar in 1987 and was appointed Queen’s Counsel in 2008. He was educated at St Paul’s School and Magdalen College, Oxford and he undertook his legal training at the City University and the Inns of Court School of Law in London. He has served as Chair of the Bar Council Member Services Board.
Outside work, Mr. Howe has been actively involved in the fundraising activities of a number of educational institutions, including Magdalen College, Queen’s Gate School and Godolphin & Latymer School of which he is Vice Chair of the Board of Governors and a Trustee.
“His passion for fundraising will be vital in helping the BHF shape its future strategy”
Dr Doug Gurr, the BHF’s Chairman, said: “We’re excited to welcome Tim Howe to the Board. His vast experience in corporate law will help ensure the BHF continues to maintain the highest standards of governance, especially in light of recent changes to how charities operate. His personal passion for fundraising will also be vital in helping the BHF shape its future strategy with the ambition of significantly growing our life-saving research programme.”
Tim Howe QC said: “I am delighted to be joining the BHF’s Board as it continues to rise to the challenges in the charity sector. I’ve seen first-hand the devastating impact that heart and circulatory diseases have on individuals and their families. But I’ve also seen the power of research in revolutionising treatments for these families. I’m looking forward to adding my expertise to the BHF’s unwavering commitment to growing its research programme and translating medical breakthroughs in to innovative treatments that save lives.”
Beating Heartbreak Worldwide
Thanks to the donations and custom of our supporters, we are the UK’s largest funder of cardiovascular research. Between 2015 and 2020, we aim to fund more than £500 million of research that could save and improve the lives of millions of people living with heart and circulatory disease in the UK, and worldwide.